Method for diagnosing abnormality in tissue samples by combination of mass spectral and optical imaging
The invention generally relates to mass spectral analysis. In certain embodiments, methods of the invention involve analyzing a lipid containing sample using a mass spectrometry technique, in which the technique utilizes a liquid phase that does not destroy native tissue morphology during analysis.
1. A method for diagnosing an abnormality, the method comprising:
performing a mass spectral analysis of a lipid containing tissue sample by directing a liquid phase that does not destroy native tissue morphology from an ionization probe onto the lipid containing tissue sample to thereby desorb one or more lipids from the sample that are analyzed by a mass spectrometer;
producing a mass spectral image of the lipid containing tissue sample based on results of the mass spectral analysis;
performing a histochemistry analysis technique on said sample to thereby stain the sample;
producing an optical image of the stained sample;
overlaying the mass spectral image with the optical image of the stained sample to produce an overlaid image; and
detecting an abnormality based on an analysis of the overlaid image.
2. The method of claim 1 wherein the liquid phase is a solvent comprising dimethylformamide (DMF), acetonitrile (ACN), or tetrahydrofuran (THF).
3. The method according to claim 2 , wherein the liquid phase comprises at least one other component.
4. The method according to claim 3 , wherein the at least one other component is selected from the group consisting of ethanol (EtOH), water (H 2 O), acetonitrile (ACN), and a combination thereof.
5. The method according to claim 1 , wherein the liquid phase is selected from the group consisting of: acetonitrile (ACN):ethanol (EtOH); methanol (MeOH):chloroform (CHCl 3 ); and acetonitrile (ACN):chloroform (CHCl 3 ).
6. The method according to claim 1 , wherein the histochemistry analysis technique is H&E staining.